Fridrik M A, Wahl G, Herbinger W, Schützenberger W, Gastl G, Huber C, Krönke M, Höpfel I
First Department of Internal Medicine, AKH-Linz, Austria.
Blut. 1989 May;58(5):261-4. doi: 10.1007/BF00320916.
We describe a patient who presented with the clinical picture of hairy cell leukemia (HCL). Bone marrow and peripheral blood lymphoma cells showed morphological and immunological features of HCL. Under recombinant alpha-2-interferon (alpha-2-IF) therapy the characteristic morphology changed from HCL to prolymphocytic leukemia (PLL). At diagnosis the lymphoma cells expressed CD24 and FMC7 surface antigen, but stained negative for surface immunoglobulins, light chains and anti-CD5. During alpha-2-IF treatment surface antigen expression changed to CD24, CD5 and FMC7. Surface IgD and lambda light chains became strongly positive. Southern Blot analysis of peripheral blood mononuclear cells showed two rearranged immunoglobulin bands at diagnosis but only one upon alpha-2-IF therapy. These data suggest, that this patient suffered from a biclonal lymphoma, HCL and PLL. While undergoing alpha-2-IF treatment the HCL came into remission, whereas the PLL clone proved to be poorly sensitive to alpha-2-IF therapy.
我们描述了一名表现出毛细胞白血病(HCL)临床症状的患者。骨髓和外周血淋巴瘤细胞显示出HCL的形态学和免疫学特征。在重组α-2干扰素(α-2-IF)治疗下,特征性形态从HCL转变为幼淋巴细胞白血病(PLL)。诊断时,淋巴瘤细胞表达CD24和FMC7表面抗原,但表面免疫球蛋白、轻链和抗CD5染色为阴性。在α-2-IF治疗期间,表面抗原表达变为CD24、CD5和FMC7。表面IgD和λ轻链变得强阳性。外周血单个核细胞的Southern印迹分析在诊断时显示两条重排的免疫球蛋白带,但在α-2-IF治疗后仅显示一条。这些数据表明,该患者患有双克隆淋巴瘤,即HCL和PLL。在接受α-2-IF治疗时,HCL进入缓解期,而PLL克隆对α-2-IF治疗表现出低敏感性。